The Neurology Clinical Trials Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Neurology Clinical Trials Market?
The market size of neurology clinical trials has seen substantial growth in recent years. It is projected to increase from $5.42 billion in 2024 to $5.80 billion in 2025, showing a compound annual growth rate (CAGR) of 7.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Neurology Clinical Trials Industry?
The Neurology Clinical Trials Global Market is expected to grow to $7.54 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%.
Download Your Free Sample of the 2025 Neurology Clinical Trials Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Neurology Clinical Trials Market?
The key drivers in the neurology clinical trials market are:
• Rising prevalence of neurological disorders globally
• Growth in neurology clinical trials that explore new treatments and interventions
• Increase in the aging population which is more susceptible to neurological disorders
• The need for improved diagnostics, symptom management, and slowed disease progression in neurological disorders
Global Market Segmentation: Identifying Major Neurology Clinical Trials Industry Segments
The neurology clinical trials market covered in this report is segmented –
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Interventional, Observational, Expanded Access
3) By Indication: Epilepsy, Parkinson’s Disease (PD), Huntington’s Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle Regeneration, Other Indications
4) By End-User: Hospitals, Clinics, Research Institutes, Other End- Users
Pre-order the 2025 Neurology Clinical Trials Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Neurology Clinical Trials Market?
The key trends in the neurology clinical trials market are:
• Innovative solutions such as monoclonal antibodies are being developed for targeted neurological pathways.
• There is a focus on improving treatment efficacy in neurology clinical trials.
• The market is seeing the acceleration of novel therapies' development.
• Newly launched drugs, targeting and reducing specific symptoms, are showing potential in slowing down disease progression.
Who Are the Top Competitors & Leading Players in the Neurology Clinical Trials Market?
Major players in the neurology clinical trials market are:
• AbbVie Inc.
• Sanofi S.A.
• Novartis AG
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• IQVIA Holdings Inc.
• Biogen Inc.
• ICON plc.
• Syneos Health
• Charles River Laboratories International Inc.
• Parexel International Corporation
• CMIC Holdings Co. Ltd.
• Medpace Holdings Inc.
• PSI CRO AG.
• Supernus Pharmaceuticals Inc.
• Worldwide Clinical Trials LLC.
• Ergomed plc.
• Biotrial S.A.S.
• Clinilabs Drug Development Corporation
• Lindus Health Ltd.
Regional Dominance: Which Area Leads the Global Neurology Clinical Trials Market?
North America was the largest region in the neurology clinical trials market in 2024
